Fibryga (Human Fibrinogen Vials) 1g

Fibryga (Human Fibrinogen) 1g vials provide essential clotting factor support for bleeding management. This sterile, lyophilized powder is used in fibrinogen deficiency treatment. Ideal for emergency and perioperative care settings. Store at ambient temperature for convenience.

Strength

Pack Size

Storage

Ambient

Manufacturer / TM Owner

OCTAPHARMA AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fibryga is used to treat acquired or congenital fibrinogen deficiency, a condition where blood lacks sufficient fibrinogen to form clots. It helps restore normal clotting function during bleeding episodes or surgical procedures. Patients with low fibrinogen levels may experience prolonged bleeding, making this treatment essential for stabilization. It is also used prophylactically before invasive procedures in at-risk patients.

Side Effects

Fibryga works by replenishing fibrinogen levels in the bloodstream, supporting the natural clotting process. Users may notice reduced bleeding duration and improved clot formation after administration. The product is designed to integrate seamlessly with the body’s existing clotting mechanisms. Effects vary based on individual fibrinogen levels and the severity of deficiency.

Precautions & Warnings

Handle Fibryga vials with care to avoid contamination; use aseptic technique during preparation and administration. Inspect the vial for particles or discoloration before use. Store at room temperature and protect from moisture. Discard any unused product or waste material according to local regulations. Always follow healthcare provider instructions for use.

Avoid Interactions

Fibryga does not typically interact with other medications, but concurrent use of anticoagulants may reduce its effectiveness. Inform your healthcare provider about all medications, including over-the-counter drugs and supplements. Avoid mixing with other intravenous solutions unless approved by a medical professional. Alcohol consumption may interfere with clotting function and should be discussed with a doctor.

Frequently Asked Questions

Fibryga is used to treat fibrinogen deficiency, helping to manage bleeding in patients with low fibrinogen levels.

Fibryga is administered intravenously after reconstitution with sterile water, following healthcare provider instructions.

Consult a healthcare provider before using Fibryga if pregnant or breastfeeding to assess potential risks and benefits.

Store Fibryga at room temperature, away from moisture and direct sunlight, and use within the expiry date on the vial.

Fibryga may be used in pediatric patients under medical supervision; dosage and safety should be determined by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.